2377655-80-4 | Pyrido[3,2-d]pyrimidin-4(3H)-one, 7-bromo-2-(difluoromethyl)- | Pyrido[3,2-d]pyrimidin-4(3H)-one, 7-bromo-2-(difluoromethyl)- |
2377656-18-1 | Pyrido[3,2-d]pyrimidine, 7-bromo-4-chloro-2-(difluoromethyl)- | Pyrido[3,2-d]pyrimidine, 7-bromo-4-chloro-2-(difluoromethyl)- |
2377679-19-9 | Nadecnemab | Nadecnemab |
2377740-99-1 | 3,4-Thiophenedicarboxylic acid, 2-amino-, 3-(1,1-dimethylethyl) 4-methyl ester | 3,4-Thiophenedicarboxylic acid, 2-amino-, 3-(1,1-dimethylethyl) 4-methyl ester |
2377762-54-2 | Dibenzothiophene, 1-bromo-9-chloro- | Dibenzothiophene, 1-bromo-9-chloro- |
2377770-18-6 | 2-(3,6-Dimethoxycarbazol-9-yl)ethylphosphonic acid | 2-(3,6-Dimethoxycarbazol-9-yl)ethylphosphonic acid |
2377845-98-0 | Nofazinlimab | Nofazinlimab |
2377847-94-2 | (1S,3S)-3-Amino-cyclohexanol hydrochloride | (1S,3S)-3-Amino-cyclohexanol hydrochloride |
2377858-38-1 | 1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo- | 1,7,9-Triazaspiro[4.5]dec-1-ene-6,10-dione, 2,4-bis(4-chlorophenyl)-8-thioxo- |
2377871-78-6 | 1,4-Benzenedicarboxaldehyde, 2,5-bis(2-propen-1-yloxy)- | 1,4-Benzenedicarboxaldehyde, 2,5-bis(2-propen-1-yloxy)- |
2377881-92-8 | Benzo[b]thiophene-2-butanoic acid, 5,5'-(1,3-propanediyl)bis[6-methoxy-γ-oxo- | Benzo[b]thiophene-2-butanoic acid, 5,5'-(1,3-propanediyl)bis[6-methoxy-γ-oxo- |
2377899-45-9 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
2377912-28-0 | Benzonitrile, 2-fluoro-5-[(E)-(3-oxo-1(3H)-isobenzofuranylidene)methyl]- | Benzonitrile, 2-fluoro-5-[(E)-(3-oxo-1(3H)-isobenzofuranylidene)methyl]- |
2377915-61-0 | Trans-1-Boc-3-amino-4-methylpyrrolidine hydrochloride | Trans-1-Boc-3-amino-4-methylpyrrolidine hydrochloride |
2377916-66-8 | Alanine, N-[[5-chloro-2-[(3-cyanophenyl)methoxy]-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-methyl- | Alanine, N-[[5-chloro-2-[(3-cyanophenyl)methoxy]-4-[(2-methyl[1,1'-biphenyl]-3-yl)methoxy]phenyl]methyl]-2-methyl- |
2377920-20-0 | 1-[(4-Methoxyphenyl)methyl]-3-methylpyrrolidin-2-one | 1-[(4-Methoxyphenyl)methyl]-3-methylpyrrolidin-2-one |
2377996-05-7 | 2377996-05-7 | 2377996-05-7 |
2378046-39-8 | 1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-5-oxido
-3,7-bis(2,4,6-trisisopropylphenyl)diindeno[7,1-de:1',7'-fg]
[1,3,2]dioxaphosphocin-5-yl]methanesulfonamide | 1,1,1-Trifluoro-N-[(11aR)-10,11,12,13-tetrahydro-5-oxido
-3,7-bis(2,4,6-trisisopropylphenyl)diindeno[7,1-de:1',7'-fg]
[1,3,2]dioxaphosphocin-5-yl]methanesulfonamide |
2378049-28-4 | HO-PEG7-CH2COOtBu
| HO-PEG7-CH2COOtBu
|
2378110-92-8 | 2,4-Bis(2-fluorophenyl)-6-phenyl-1,3,5-triazine | 2,4-Bis(2-fluorophenyl)-6-phenyl-1,3,5-triazine |
2378114-72-6 | Lanreotide acetate | Lanreotide acetate |
2378131-12-3 | 5',5""-methylenebis(2'-amino-[1,1':3',1"-terphenyl]-4,4"-dicarboxylic acid) | 5',5""-methylenebis(2'-amino-[1,1':3',1"-terphenyl]-4,4"-dicarboxylic acid) |
2378150-09-3 | 3,6,9,12,15,18,21,24,27,30-Decaoxatritriacont-32-yn-1-ol | 3,6,9,12,15,18,21,24,27,30-Decaoxatritriacont-32-yn-1-ol |
2378158-44-0 | Cefadroxil Impurity 10 | Cefadroxil Impurity 10 |
2378158-45-1 | Cefadroxil Impurity 6 | Cefadroxil Impurity 6 |
2378173-15-8 | PF-06928215 | PF-06928215 |
2378179-91-8 | MIP-202(Zr) | MIP-202(Zr) |
2378180-01-7 | 2'-amino-5'-cyano-[1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid | 2'-amino-5'-cyano-[1,1':3',1''-terphenyl]-4,4''-dicarboxylic acid |
2378188-16-8 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
2378258-52-5 | PROTAC K-Ras Degrader-1 | PROTAC K-Ras Degrader-1 |
2378259-33-5 | Glycine, N-[4-chloro-2-hydroxy-5-(1-methylcyclopropyl)phenyl]- | Glycine, N-[4-chloro-2-hydroxy-5-(1-methylcyclopropyl)phenyl]- |
2378259-45-9 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
2378261-80-2 | THP-PEG4-Pyrrolidine(N-Boc)-CH2OH | THP-PEG4-Pyrrolidine(N-Boc)-CH2OH |
2378261-81-3 | THP-PEG4-Pyrrolidine(N-Me)-CH2OH | THP-PEG4-Pyrrolidine(N-Me)-CH2OH |
2378261-83-5 | K-Ras ligand-Linker Conjugate 4 | K-Ras ligand-Linker Conjugate 4 |
2378261-85-7 | K-Ras ligand-Linker Conjugate 5 | K-Ras ligand-Linker Conjugate 5 |
2378261-87-9 | K-Ras ligand-Linker Conjugate 3 | K-Ras ligand-Linker Conjugate 3 |
2378261-89-1 | K-Ras ligand-Linker Conjugate 6 | K-Ras ligand-Linker Conjugate 6 |
2378262-52-1 | 1,3,2-Dioxaborolane, 2-[3-(methoxymethoxy)-1-naphthalenyl]-4,4,5,5-tetramethyl- | 1,3,2-Dioxaborolane, 2-[3-(methoxymethoxy)-1-naphthalenyl]-4,4,5,5-tetramethyl- |
2378356-17-1 | [1,1'-Biphenyl]-4-amine, 2'-(9H-carbazol-9-yl)- | [1,1'-Biphenyl]-4-amine, 2'-(9H-carbazol-9-yl)- |
2378380-49-3 | 2-(2-((7-(2-(aminomethyl)-3-fluoropyridin-4-yl)benzofuran-5-yl)methoxy)phenyl)acetic acid | 2-(2-((7-(2-(aminomethyl)-3-fluoropyridin-4-yl)benzofuran-5-yl)methoxy)phenyl)acetic acid |
2378391-11-6 | Benzoic acid, 4-[2,6-bis(4-carboxyphenyl)-4-pyrimidinyl]- | Benzoic acid, 4-[2,6-bis(4-carboxyphenyl)-4-pyrimidinyl]- |
2378406-17-6 | 2-[(2,4,5-Trihydroxyphenyl)methylene]-3(2H)-benzofuranone | 2-[(2,4,5-Trihydroxyphenyl)methylene]-3(2H)-benzofuranone |
2378407-27-1 | Uliledlimab | Uliledlimab |
2378409-07-3 | Ticagrelor Related Compound 19 | Ticagrelor Related Compound 19 |
2378422-35-4 | 3-Pyridinecarbonitrile, 1,2,5,6-tetrahydro-4-methyl-2,6-dioxo-5-[(5-phenyl-2-furanyl)methylene]-, (5Z)- | 3-Pyridinecarbonitrile, 1,2,5,6-tetrahydro-4-methyl-2,6-dioxo-5-[(5-phenyl-2-furanyl)methylene]-, (5Z)- |
2378428-27-2 | Mal-amido-PEG12-acid | Mal-amido-PEG12-acid |
2378463-76-2 | Androsta-5,16-dien-3-ol, 17-(1-oxido-3-pyridinyl)-, (3β)- | Androsta-5,16-dien-3-ol, 17-(1-oxido-3-pyridinyl)-, (3β)- |
2378489-93-9 | (2S)-2-AMINO-2-(3-BROMO-5-CHLOROPHENYL)ETHAN-1-OL HYDROCHLORIDE | (2S)-2-AMINO-2-(3-BROMO-5-CHLOROPHENYL)ETHAN-1-OL HYDROCHLORIDE |
2378498-82-7 | 10-(2,12-di-tert-butyl-5,9-dioxa-13b- boranaphtho[3,2,1-de]anthracen-7-yl)- 9,9-dimethyl-9,10-dihydroacridine | 10-(2,12-di-tert-butyl-5,9-dioxa-13b- boranaphtho[3,2,1-de]anthracen-7-yl)- 9,9-dimethyl-9,10-dihydroacridine |
2378498-93-0 | 7-bromo-2,12-bis(1,1-dimethylethyl)-[1,4]Benzoxaborino[2,3,4-kl]phenoxaborin | 7-bromo-2,12-bis(1,1-dimethylethyl)-[1,4]Benzoxaborino[2,3,4-kl]phenoxaborin |
2378501-46-1 | 2-amino-2-(2,6-dichlorophenyl)acetic acid hydrochloride | 2-amino-2-(2,6-dichlorophenyl)acetic acid hydrochloride |
2378501-48-3 | 1,4-Oxazepine-4(5H)-carboxylic acid, 6-(bromomethyl)-6-fluorotetrahydro-, 1,1-dimethylethyl ester | 1,4-Oxazepine-4(5H)-carboxylic acid, 6-(bromomethyl)-6-fluorotetrahydro-, 1,1-dimethylethyl ester |
2378514-41-9 | Benzyl(3,5-dibromophenyl)sulfane | Benzyl(3,5-dibromophenyl)sulfane |
2378536-29-7 | PYR16 | PYR16 |
2378582-39-7 | 2,6-Piperidinedione, 3-(1,3-dihydro-4-mercapto-1-oxo-2H-isoindol-2-yl)- | 2,6-Piperidinedione, 3-(1,3-dihydro-4-mercapto-1-oxo-2H-isoindol-2-yl)- |
2378590-46-4 | Fmoc-N-amido-PEG15-acid | Fmoc-N-amido-PEG15-acid |
2378608-10-5 | GNE-8324 | GNE-8324 |
2378614-29-8 | Spiro[3H-indole-3,7'(6'H)-pyrrolo[1,2-a]pyrazine]-1',2,4'(1H)-trione, 6'-(1,3-benzodioxol-5-yl)-2',3',8',8'a-tetrahydro-2'-methyl-, (8'aR)- | Spiro[3H-indole-3,7'(6'H)-pyrrolo[1,2-a]pyrazine]-1',2,4'(1H)-trione, 6'-(1,3-benzodioxol-5-yl)-2',3',8',8'a-tetrahydro-2'-methyl-, (8'aR)- |
2378617-67-3 | Integrin-IN-2 | Integrin-IN-2 |
2378617-96-8 | HWL-088 | HWL-088 |
2378626-29-8 | TED-347 | TED-347 |
2378628-49-8 | Thieno[3,2-b]thiophene, 3-methoxy- | Thieno[3,2-b]thiophene, 3-methoxy- |
2378640-92-5 | ENPP1 Inhibitor C | ENPP1 Inhibitor C |
2378663-15-9 | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3S,4R)-4-methyl-3-piperidinyl]- | 7H-Pyrrolo[2,3-d]pyrimidin-4-amine, N-methyl-N-[(3S,4R)-4-methyl-3-piperidinyl]- |
2378692-15-8 | Amlitelimab | Amlitelimab |
2378750-29-7 | 1-Naphthalenamine, 4-(3-chlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4R)-rel- | 1-Naphthalenamine, 4-(3-chlorophenyl)-1,2,3,4-tetrahydro-N-methyl-, (1R,4R)-rel- |
2378751-17-6 | 2,2'-Bioxazole, 4,4'-dicyclohexyl-4,4',5,5'-tetrahydro-, (4R,4'R)- | 2,2'-Bioxazole, 4,4'-dicyclohexyl-4,4',5,5'-tetrahydro-, (4R,4'R)- |
2378754-22-2 | 1-ETHYNYL-4-FLUOROBENZENE-2,3,5,6-D4 | 1-ETHYNYL-4-FLUOROBENZENE-2,3,5,6-D4 |
2378755-50-9 | Erythromycin-13C,d3 | Erythromycin-13C,d3 |
2378781-91-8 | 1,3,5-tris(2-methyl-1H-imidazol-1-yl)benzene | 1,3,5-tris(2-methyl-1H-imidazol-1-yl)benzene |
2378801-85-3 | PROTAC Bcl2 degrader-1 | PROTAC Bcl2 degrader-1 |
2378802-47-0 | SLF TFA | SLF TFA |
2378802-50-5 | 4-arm-PEG-hydrazidehydrazide | 4-arm-PEG-hydrazidehydrazide |
2378808-45-6 | Arg-Gly-Asp(TFA salt) | Arg-Gly-Asp(TFA salt) |
2378821-30-6 | 1H-Pyrrolo[2,3-b]pyridine-1-carboxylic acid, 2,3-dihydro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester | 1H-Pyrrolo[2,3-b]pyridine-1-carboxylic acid, 2,3-dihydro-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-, 1,1-dimethylethyl ester |
2378855-09-3 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
2379277-60-6 | Stephalonine L | Stephalonine L |
2379279-96-4 | Boronic acid, B-[2-methoxy-3-(3,8,9,10-tetrahydrocyclopenta[c]pyrazolo[4,3-f]quinolin-7-yl)phenyl]- | Boronic acid, B-[2-methoxy-3-(3,8,9,10-tetrahydrocyclopenta[c]pyrazolo[4,3-f]quinolin-7-yl)phenyl]- |
2379290-24-9 | 1.3.6.8-tetrabromopyrene-4,5,9,10-tetraketone | 1.3.6.8-tetrabromopyrene-4,5,9,10-tetraketone |
2379295-70-0 | 2-Pyrrolidinemethanol, α-[(phenylsulfonyl)methyl]-, (αS,2S)- | 2-Pyrrolidinemethanol, α-[(phenylsulfonyl)methyl]-, (αS,2S)- |
2379295-73-3 | 2-Pyrrolidinemethanol, α-[(phenylsulfonyl)methyl]-, (αR,2R)- | 2-Pyrrolidinemethanol, α-[(phenylsulfonyl)methyl]-, (αR,2R)- |
2379299-19-9 | 2-Bromo-2′-chloro-spiro[9H-fluorene-9,9′-[9H]xanthene] | 2-Bromo-2′-chloro-spiro[9H-fluorene-9,9′-[9H]xanthene] |
2379311-62-1 | (S)-2-(1-Aminoethyl)-4-fluorophenol hydrochloride | (S)-2-(1-Aminoethyl)-4-fluorophenol hydrochloride |
2379320-84-8 | Carbamic acid,N-(7-iodopyrrolo[2,1-f][1,2,4]triazin-4-yl)-, 1,1-dimethylethyl este | Carbamic acid,N-(7-iodopyrrolo[2,1-f][1,2,4]triazin-4-yl)-, 1,1-dimethylethyl este |
2379321-65-8 | 1-(4-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbaldehyde | 1-(4-Chloro-2-fluorophenyl)-1H-pyrazole-4-carbaldehyde |
2379321-70-5 | 3-Bromo-2-chloro-5-isopropylbenzoic acid | 3-Bromo-2-chloro-5-isopropylbenzoic acid |
2379325-42-3 | Duloxetine EP Impurity F (oxalate)Q: What is
Duloxetine EP Impurity F (oxalate) Q: What is the CAS Number of
Duloxetine EP Impurity F (oxalate) | Duloxetine EP Impurity F (oxalate)Q: What is
Duloxetine EP Impurity F (oxalate) Q: What is the CAS Number of
Duloxetine EP Impurity F (oxalate) |
2379390-76-6 | Probe 388-9 | Probe 388-9 |
2379392-61-5 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
2379394-94-0 | Cyclobutanol, 3-(aminomethyl)-1-methyl-, hydrochloride (1:1), cis- | Cyclobutanol, 3-(aminomethyl)-1-methyl-, hydrochloride (1:1), cis- |
2379402-85-2 | 2-Pyrazinecarboxamide, N-[(1S)-2-[(3-hydroxy-3-methyl-1-oxobutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]- | 2-Pyrazinecarboxamide, N-[(1S)-2-[(3-hydroxy-3-methyl-1-oxobutyl)amino]-2-oxo-1-(phenylmethyl)ethyl]- |
2379404-33-6 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
2379422-72-5 | LY3154885 | LY3154885 |
2379438-80-7 | Compound Y-1 | Compound Y-1 |
2379454-98-3 | INDEX NAME NOT YET ASSIGNED | INDEX NAME NOT YET ASSIGNED |
2379460-04-3 | 9-chloronaphtho[2,1-b]benzofuran | 9-chloronaphtho[2,1-b]benzofuran |
2379538-57-3 | (3-Bromo-2-chloro-5-fluorophenyl)boronic acid | (3-Bromo-2-chloro-5-fluorophenyl)boronic acid |
2379550-55-5 | 2-Methyl-1,2,3,4-tetrahydro-isoquinoline-6-boronic acid picol ester hydrochloride | 2-Methyl-1,2,3,4-tetrahydro-isoquinoline-6-boronic acid picol ester hydrochloride |
2379550-82-8 | SHS4121705 | SHS4121705 |